Vasopressin for vasodilatory shock

This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient-an area of health care that has become increasingly complex. It will review recent advances (including evolving and controversial data) in drug therapy for adult ICU patients and assess these new modalities in terms of clinical, humanistic, and economic outcomes.